Cerenis Therapeutics

Cerenis Therapeutics is an international biopharmaceutical company developing novel HDL therapies for the treatment of cardiovascular and metabolic diseases. The company is focusing on a portfolio of HDL therapies, including HDL mimetics for the rapid regression of atherosclerotic plaque in high-risk patients, and HDL elevators for patients with low HDL.
The Company is headquartered in Lab├Ęge, France and has one office in the USA.